Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection
Moore P.S., and Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 332 (1995) 1181-1185
Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis
[Epub ahead of print]
Gasperini P., Sakakibara S., and Tosato G. Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis. J Leukoc Biol (2008) [Epub ahead of print]
Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene
Miki T., Bottaro D.P., Fleming T.P., Smith C.L., Burgess W.H., Chan A.M., et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89 (1992) 246-250
Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2
Chaffer C.L., Brennan J.P., Slavin J.L., Blick T., Thompson E.W., and Williams E.D. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66 (2006) 11271-11278
Modulation of the expression of the FGFR2-IIIb and FGFR2-IIIc molecules in dermatofibroma
Skroza N., Rotolo S., Ceccarelli S., Romano F., Innocenzi D., Frati L., et al. Modulation of the expression of the FGFR2-IIIb and FGFR2-IIIc molecules in dermatofibroma. J Dermatol Sci 51 (2008) 53-57
A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome
Tanimoto Y., Yokozeki M., Hiura K., Matsumoto K., Nakanishi H., Matsumoto T., et al. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome. J Biol Chem 279 (2004) 45926-45934